Publications by authors named "Peter Osin"

Claim this Profile
C
Clinical outcomes in patients with triple negative or HER2 positive lobular breast cancer: a single institution experience.
Alicia Okines, Tazia Irfan, Bernice Asare, Kabir Mohammed, Peter Osin

Breast Cancer Res Treat· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The INTEND 1 randomized controlled trial of duct endoscopy as an indicator of margin excision in breast conservation surgery.
Gerald Gui, Effrosyni Panopoulou, Sarah Tang, Dominique Twelves, Mohammed Kabir, Peter Osin

Breast Cancer Res Treat· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inactivating Mutations Are Enriched in Advanced Breast Cancer and Contribute to Endocrine Therapy Resistance.
Alex Pearson, Paula Proszek, Javier Pascual, Charlotte Fribbens, Monee K Shamsher, Peter Osin

Clin Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Analysis of ESR1 mutation in circulating tumor DNA demonstrates evolution during therapy for metastatic breast cancer.
Gaia Schiavon, Sarah Hrebien, Isaac Garcia-Murillas, Rosalind J Cutts, Alex Pearson, Peter Osin

Sci Transl Med· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutation tracking in circulating tumor DNA predicts relapse in early breast cancer.
Isaac Garcia-Murillas, Gaia Schiavon, Britta Weigelt, Charlotte Ng, Sarah Hrebien, Peter Osin

Sci Transl Med· August 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Integrative analyses identify modulators of response to neoadjuvant aromatase inhibitors in patients with early breast cancer.
Elena López-Knowles, Paul M Wilkerson, Ricardo Ribas, Helen Anderson, Alan Mackay, Peter Osin

Breast Cancer Res· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Noninvasive detection of HER2 amplification with plasma DNA digital PCR.
Heidrun Gevensleben, Isaac Garcia-Murillas, Monika K Graeser, Gaia Schiavon, Peter Osin

Clin Cancer Res· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
DNA promoter hypermethylation profiles in breast duct fluid.
Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Tim Dexter, Ann Ward

Breast Cancer Res Treat· June 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Molecular profiling of aromatase inhibitor-treated postmenopausal breast tumors identifies immune-related correlates of resistance.
Anita K Dunbier, Zara Ghazoui, Helen Anderson, Janine Salter, Ashutosh Nerurkar, Peter Osin

Clin Cancer Res· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extreme loss of immunoreactive p-Akt and p-Erk1/2 during routine fixation of primary breast cancer.
Isabel F Pinhel, Fiona A Macneill, Margaret J Hills, Janine Salter, Simone Detre, Peter Osin

Breast Cancer Res· February 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The feasibility of nipple aspiration and duct lavage to evaluate the breast duct epithelium of women with increased breast cancer risk.
Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Ann Ward, Clare M Isacke

Eur J Cancer· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The anatomy of fluid-yielding ducts in breast cancer.
Dominique Twelves, Ashutosh Nerurkar, Peter Osin, Ann Ward, Clare M Isacke

Breast Cancer Res Treat· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metastatic breast cancer presenting as a primary hindgut neuroendocrine tumour.
Alicia F C Okines, Eliza A Hawkes, Sheela Rao, Nicholas VAN As, Henry Marsh, Peter Osin

Anticancer Res· July 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women.
Anita K Dunbier, Helen Anderson, Zara Ghazoui, Elizabeth J Folkerd, Roger A'hern, Peter Osin

J Clin Oncol· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Testing the feasibility of intra-operative sentinel lymph node touch imprint cytology.
Alireza Hamidian Jahromi, Sankaran Narayanan, Fiona MacNeill, Peter Osin, Ashutash Nerurkar

Ann R Coll Surg Engl· May 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Gene promoter hypermethylation in ductal lavage fluid from healthy BRCA gene mutation carriers and mutation-negative controls.
Imogen Locke, Zsofia Kote-Jarai, Mary Jo Fackler, Elizabeth Bancroft, Peter Osin

Breast Cancer Res· May 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Loss of heterozygosity at the BRCA1 and BRCA2 loci detected in ductal lavage fluid from BRCA gene mutation carriers and controls.
Imogen Locke, Zsofia Kote-Jarai, Elizabeth Bancroft, Sarah Bullock, Sarah Jugurnauth, Peter Osin

Cancer Epidemiol Biomarkers Prev· July 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The diagnosis and management of pre-invasive breast disease: the role of new diagnostic techniques.
Ashutosh Nerurkar, Peter Osin

Breast Cancer Res· December 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two percent of men with early-onset prostate cancer harbor germline mutations in the BRCA2 gene.
Stephen M Edwards, Zsofia Kote-Jarai, Julia Meitz, Rifat Hamoudi, Questa Hope, Peter Osin

Am J Hum Genet· January 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2.
Sunil R Lakhani, Marc J Van De Vijver, Jocelyne Jacquemier, Thomas J Anderson, Peter P Osin

J Clin Oncol· May 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Concomitant inactivation of p53 and Chk2 in breast cancer.
Alexandra Sullivan, Martin Yuille, Claire Repellin, Archana Reddy, Olivier Reelfs, Peter Osin

Oncogene· February 2002

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis